BRPI0912687A2 - uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia - Google Patents

uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia

Info

Publication number
BRPI0912687A2
BRPI0912687A2 BRPI0912687A BRPI0912687A BRPI0912687A2 BR PI0912687 A2 BRPI0912687 A2 BR PI0912687A2 BR PI0912687 A BRPI0912687 A BR PI0912687A BR PI0912687 A BRPI0912687 A BR PI0912687A BR PI0912687 A2 BRPI0912687 A2 BR PI0912687A2
Authority
BR
Brazil
Prior art keywords
hyperhomocysteinemia
treatment
probiotic bacteria
probiotic
bacteria
Prior art date
Application number
BRPI0912687A
Other languages
English (en)
Inventor
Gian Paolo Strozzi
Giovanni Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of BRPI0912687A2 publication Critical patent/BRPI0912687A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
BRPI0912687A 2008-05-16 2009-04-08 uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia BRPI0912687A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000898A ITMI20080898A1 (it) 2008-05-16 2008-05-16 Uso di batteri probiotici per il trattamento della iperomocisteinemia
PCT/EP2009/054221 WO2009138300A1 (en) 2008-05-16 2009-04-08 Use of probiotic bacteria for the treatment of hyperhomocysteinaemia

Publications (1)

Publication Number Publication Date
BRPI0912687A2 true BRPI0912687A2 (pt) 2016-01-26

Family

ID=40302761

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0912687A BRPI0912687A2 (pt) 2008-05-16 2009-04-08 uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia

Country Status (11)

Country Link
US (1) US20110135608A1 (pt)
EP (1) EP2276498B1 (pt)
JP (1) JP2011520821A (pt)
CN (1) CN102099044B (pt)
BR (1) BRPI0912687A2 (pt)
DK (1) DK2276498T3 (pt)
ES (1) ES2608758T3 (pt)
IT (1) ITMI20080898A1 (pt)
PL (1) PL2276498T3 (pt)
RU (1) RU2010147885A (pt)
WO (1) WO2009138300A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011044934A1 (en) * 2009-10-14 2011-04-21 Probiotical S.P.A Probiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
CN102429920A (zh) * 2011-11-30 2012-05-02 胡志超 一种多关联降血酸组合物及其制备方法
ITMI20112238A1 (it) * 2011-12-09 2013-06-10 Probiotical Spa Ceppi di batteri probiotici produttori di vitamina b12
CN112195128B (zh) * 2014-08-29 2023-05-02 科.汉森有限公司 益生菌青春双歧杆菌菌株
JP2017536828A (ja) * 2014-11-26 2017-12-14 プロバイオティカル・ソシエタ・ペル・アチオニＰｒｏｂｉｏｔｉｃａｌ Ｓ．Ｐ．Ａ． 人体における長期持続性ホメオスタシス状態の維持のためのラクトバチルスおよびビフィドバクテリウム株
RU2720629C2 (ru) 2014-12-29 2020-05-12 Мофин С.Р.Л. Изготовление бездрожжевой легкоусвояемой пиццы с использованием теста, содержащего молочнокислые бактерии
CN107772458A (zh) * 2017-09-29 2018-03-09 赤峰赛佰诺制药有限公司 一种用于高同型半胱氨酸血症的配方粉及其制备方法
CN113398151A (zh) * 2021-06-29 2021-09-17 苏州麦若尔生物科技有限公司 一种用于治疗高同型半胱氨酸血症的益生菌与益生元结合发酵乳及其制备方法和用途
CN115181683B (zh) * 2022-02-10 2023-10-03 江南大学 一株高富集有机锌的短双歧杆菌

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1383829A (zh) * 2001-05-08 2002-12-11 肖钢 用于预防或治疗高同型半胱氨酸血症及其相关疾病的复方叶酸制剂
BRPI0418986A (pt) * 2004-08-05 2007-12-11 Anidral Srl cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos
WO2006102536A2 (en) * 2005-03-23 2006-09-28 University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
ITMI20061841A1 (it) * 2006-09-27 2008-03-28 Mofin S R L Colture liquide microbiche ad elevata stabilita' ed attivita' fermentativa
JP5140791B2 (ja) * 2008-11-27 2013-02-13 森下仁丹株式会社 乳酸菌含有血中ホモシステイン低減剤

Also Published As

Publication number Publication date
ES2608758T3 (es) 2017-04-12
ITMI20080898A1 (it) 2009-11-17
DK2276498T3 (en) 2016-12-12
JP2011520821A (ja) 2011-07-21
CN102099044B (zh) 2014-06-11
RU2010147885A (ru) 2012-06-27
WO2009138300A1 (en) 2009-11-19
US20110135608A1 (en) 2011-06-09
CN102099044A (zh) 2011-06-15
EP2276498A1 (en) 2011-01-26
EP2276498B1 (en) 2016-10-19
PL2276498T3 (pl) 2017-08-31

Similar Documents

Publication Publication Date Title
NL301192I2 (nl) Finerenon en zijn zouten, solvaten en solvaten van de zouten daarvan
BRPI0912687A2 (pt) uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
BRPI1013698A2 (pt) métodos para tratamento com o uso de terapia de combinação
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0916862A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
BRPI1010540A2 (pt) "anticorpos especéficos para dkk-1 e seus usos"
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
BRPI1014759A2 (pt) composto útil para o tratamento de doenças degenerativas e inflamatórias
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
BR112012004836A2 (pt) pirazinilpiridinas úteis para o tratamento de doenças proliferativas
BRPI0813670A2 (pt) Compostos para tratamento
BRPI1009783A2 (pt) compostos para o tratamento de distúrbios metabólicos.
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI1007995A2 (pt) orto-aminoamidas para o tratamento de cãncer.
BR112013034055A2 (pt) alcaftadina para uso no tratamento de urticária
BR112013022523A2 (pt) uso de glicopirrolato para o tratamento de taquicardia
BRPI0818170A2 (pt) 5-cianotienopiridinas para o tratamento de tumores.
BRPI1009448A2 (pt) combinações farmacêuticas compreendendo edea119/bay 869766 para o tratamento de cânceres específicos
BRPI0915905A2 (pt) uso de derivados de pirimidilaminobenzamida para o tratamento de fibrose
BRPI0921404A2 (pt) sistema para tratamento de superfície de objetos
BRPI0907956A2 (pt) Uso de ranolazina para o tratamento de doenças cardiovasculares

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]